Endo Hits Impax With $100M Suit Over Painkiller IP Agreement
Endo Pharmaceuticals Inc. launched a suit in New Jersey federal court Wednesday claiming generic drugmaker Impax Laboratories owes it more than $100 million for breaching a patent licensing agreement by refusing...To view the full article, register now.
Already a subscriber? Click here to view full article